|
|
||||||||
Clinical Chemistry, Vol 22, 1697-1701, Copyright © 1976 by American Association for Clinical Chemistry
DN Bailey and PI Jatlow
We describe a method for the simultaneous gas-chromatographic analysis of imipramine and desipramine (the active N-desmethyl metabolite) at therapeutic concentrations in human plasma, with use of a nitrogen detector. Imipramine is measured as the unchanged base and desipramine as its N-tribluoroacetyl derivative. Promazine is the internal standard. The lower limit of sensitivity is 5 mug/liter for each drug, and the within-day coefficients of variation for the determination of imipramine and desipramine, respectively, are 6.0% and 3.3%. We measured concentrations of these drugs both in patients receiving therapeutic doses of imipramine and in those who had ingested an overdose.
The following articles in journals at HighWire Press have cited this article:
![]() |
W.P. Tormey, H. Crosse, and A. Pierce Chemical Toxicology for the Coroner Human and Experimental Toxicology, September 1, 1989; 8(5): 375 - 379. [Abstract] [PDF] |
||||
![]() |
A.H. Stead and A.C. Moffat A Collection of Therapeutic, Toxic and Fatal Blood Drug Concentrations in Man Human and Experimental Toxicology, January 1, 1983; 2(3): 437 - 464. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |